Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

1. Exploring cellular immunotherapy platforms in multiple myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   МақолаCAR-T cell therapy researchHeliyon20241 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.102962

2. Exploring Cellular Immunotherapy Platforms in Multiple Myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   ПрепринтCAR-T cell therapy researchSSRN Electronic Journal20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.preprint.000164

3. The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders

   Farag M. A. Altalbawy, Zarrina Babamuradova, Lalji Baldaniya +7

   Шарҳ мақолаImmune Cell Function and InteractionExperimental Cell Research20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000131